Ask AI
ProCE Banner Series

Tuning in to TYK2: Innovation in Oral Psoriasis Treatment for NPs and PAs

TYK2 inhibitors represent a novel class with a distinct mechanism of action that requires thoughtful integration into individualized care plans. Understanding the immunopathogenic rationale for targeting specific kinases within the JAK-STAT family is important to choose optimal therapies for patients with moderate to severe psoriasis.

  AAPA
  | ANCC with Pharmacotherapy Credit
Who Should Attend

This activity is intended for nurse practitioners and physician associates who are involved in the management of patients with moderate to severe psoriasis.

Topics

Psoriasis, oral psoriasis treatment, TYK2 inhibitors

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psoriasis.

Target Audience
This activity is intended for nurse practitioners and physician associates who are involved in the management of patients with moderate to severe psoriasis.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Distinguish the role of TYK2 within the JAK-STAT signaling pathway and its relevance to selective therapeutic targeting in moderate to severe psoriasis

  • Apply clinical evidence and patient-specific factors to appropriately incorporate small molecule therapies into individualized treatment strategies for moderate to severe psoriasis

  • Develop personalized management plans that leverage small molecule therapies to address unmet needs and improve outcomes in diverse patients with moderate to severe psoriasis

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hour of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Partners for Advancing Clinical Education (Partners) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation. 

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest

Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners' policies.

Acknowledgement

Provided by

Provided by Partners for Advancing Clinical Education (Partners)

Partners for Advancing Clinical Education (Partners) 2025

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191